Company / Operating Margin
Bionano Genomics, Inc. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-117.0%
FY2025
5-year range
-596.0% / -117.0%
FY2021-FY2025
Trend
+80.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -473.7% to -117.0% over the past 2 years.
Based on SEC 10-K filings.
-117.0% in FY2025 with a 5-year CAGR of +138.5%.
Improved from -473.7% to -117.0% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +356.8pp
- 5-Year Change
- +138.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 80.4% year-over-year.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -117.0% | +80.4% |
| FY2024 | -596.0% | -25.8% |
| FY2023 | -473.7% | +0.0% |
| FY2022 | -473.7% | -4.5% |
| FY2021 | -453.4% | -77.5% |
| FY2020 | -255.4% | -50.2% |
| FY2019 | -170.1% | +30.4% |
| FY2018 | -244.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026